28 October 2026 Quarterly Activities Report & Appendix 4C For the Period Ending 30 September 2026 ® First U.S. ROXUS Prescriptions Fulfilled and Final Phase II Report Completes FDA Pharmacokinetic Dataset Highlights ® • First ROXUS prescriptions fulfilled in the U.S. (subsequent to quarter...